Nicotinyl methylamide
![]() | |
![]() | |
Names | |
---|---|
Preferred IUPAC name N-Methylpyridine-3-carboxamide | |
Other names N-Methylnicotinamide; N-Methylniacinamide | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
Abbreviations | NAN[citation needed] |
ChEBI |
|
ChemSpider |
|
DrugBank |
|
ECHA InfoCard | 100.003.679 ![]() |
EC Number |
|
MeSH | C008472 |
PubChem CID |
|
UNII |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
Properties | |
Chemical formula | C7H8N2O |
Molar mass | 136.154 g·mol−1 |
Pharmacology | |
A05AB01 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). ![]() ![]() ![]() Infobox references |
Chemical compound
Nicotinyl methylamide is an experimental drug with no approved indication.[1] It is also a metabolite of nicotinamide (vitamin B3) and is found in urine.[2]
See also
- Niacin
- Niacinamide
References
- v
- t
- e
Bile and liver therapy (A05)
- bile acid
- Cyclobutyrol
- Elafibranor
- Hymecromone
- Maralixibat chloride
- Menbutone
- Nicotinyl methylamide
- Odevixibat
- Piprozolin
![]() | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
![]() | This article about a heterocyclic compound is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e